Cargando…

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis

Introduction: Currently, faecal calprotectin (FC) is the predominate faecal biomarker utilised in clinical practice to monitor Crohn’s disease (CD) activity. However, there are several potential faecal biomarkers described in the literature. We performed a meta-analysis to determine the accuracy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bohra, Anuj, Mohamed, Ghada, Vasudevan, Abhinav, Lewis, Diana, Van Langenberg, Daniel R., Segal, Jonathan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216423/ https://www.ncbi.nlm.nih.gov/pubmed/37239079 http://dx.doi.org/10.3390/biomedicines11051408

Ejemplares similares

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
por: Baillet, Pierre, et al.
Publicado: (2018)

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease
por: e Penna, Francisco Guilherme Cancela, et al.
Publicado: (2020)

Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study
por: Swale, Andrew, et al.
Publicado: (2014)

Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020)

Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021)

Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study
por: Stawczyk-Eder, Kamila, et al.
Publicado: (2015)

Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis
por: Bathe, Anna Luisa, et al.
Publicado: (2019)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
por: Azouz, Hanan Galal, et al.
Publicado: (2021)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
por: Ellakany, Walid Ismail, et al.
Publicado: (2022)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas
por: Stevens, Toer W, et al.
Publicado: (2019)

Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease
por: Bohra, Anuj, et al.
Publicado: (2022)

The association between faecal host DNA or faecal calprotectin and feed efficiency in pigs fed yeast-enriched protein concentrate
por: Slinger, K. R., et al.
Publicado: (2019)

Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn’s Disease: Are We There Yet?
por: Bohra, Anuj, et al.
Publicado: (2023)

Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn’s Disease
por: Mendall, Michael A., et al.
Publicado: (2016)

Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
por: Roberts, Rebecca L., et al.
Publicado: (2018)

Comparison of a rapid test and an automated method for faecal calprotectin measurement
por: Martins, Sandra, et al.
Publicado: (2019)

Predictive value of faecal calprotectin in ulcerative colitis – single centre experience
por: Grgić, Dora, et al.
Publicado: (2022)

Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
por: Fu, Yu, et al.
Publicado: (2017)

Diffusion-weighted imaging for evaluating inflammatory activity in Crohn’s disease: comparison with histopathology, conventional MRI activity scores, and faecal calprotectin
por: Pendsé, D. A., et al.
Publicado: (2016)

Levels of Faecal Calprotectin and Magnetic Resonance Enterocolonography Correlate with Severity of Small Bowel Crohn’s Disease: A Retrospective Cohort Study
por: Ye, Lei, et al.
Publicado: (2017)

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
por: Komraus, Marzena, et al.
Publicado: (2012)

Effect of age, gestation and lactation on faecal IgA and calprotectin concentrations in dogs
por: Grellet, Aurélien, et al.
Publicado: (2014)

Faecal calprotectin and gut microbiota do not predict enteropathy in very preterm infants
por: Campeotto, Florence, et al.
Publicado: (2020)

New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
por: Castiglione, Vincent, et al.
Publicado: (2022)

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015)

Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs
por: Hang, Ingrid, et al.
Publicado: (2013)

The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
por: Lué, Alberto, et al.
Publicado: (2020)

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010)

Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting
por: Noebauer, Britta, et al.
Publicado: (2017)

Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease
por: Zhang, Wei, et al.
Publicado: (2019)

Faecal Calprotectin and 7-α Cholestenone Levels in Microscopic Colitis: Experience from Edinburgh
por: Davie, Matt, et al.
Publicado: (2020)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
por: Blad, Nathalie, et al.
Publicado: (2022)

Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs
por: Di Brizzi, Eugenia Veronica, et al.
Publicado: (2022)

Author Correction: Levels of Faecal Calprotectin and Magnetic Resonance Enterocolonography Correlate with Severity of Small Bowel Crohn’s Disease: A Retrospective Cohort Study
por: Ye, Lei, et al.
Publicado: (2018)

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease
por: Galazzo, Gianluca, et al.
Publicado: (2019)

The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re‐introduction
por: Logan, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fmsibvnp6357vq0tgcgaeg7peu